AMH is one of the first tests ordered in a fertility workup. The result often triggers sharp anxiety — 'low AMH' sounds like a verdict. In reality, it isn't — and this article explains why.
To interpret AMH correctly, you need to understand what it actually measures and, just as importantly, what it doesn't. And what to do next if the result comes back below the reference range.
Anti-Müllerian hormone is a protein produced by the cells of small growing follicles in the ovaries. Its level in the blood reflects the number of those follicles — and so indirectly indicates the remaining egg supply in the ovaries. This supply is called the ovarian reserve.
Women are born with a fixed number of eggs — around one to two million at birth. By puberty roughly 300,000 to 500,000 remain. Each month, regardless of ovulation, pregnancy or contraception, a cohort of follicles is recruited and then lost. This process is irreversible. AMH reflects how many 'active' follicles remain at a given point in time.
One practical advantage of AMH over other hormonal markers is that its level barely varies across the menstrual cycle. FSH and oestradiol must be tested on a specific cycle day; AMH can be tested on any day. This makes it a convenient screening tool.
Reference ranges for AMH depend on the laboratory and the assay method — so comparing results from different labs without accounting for their standards is misleading. That said, the approximate values used by most European clinics: above 3.5–4 ng/ml is considered high (typical of younger women with good reserve; may also indicate PCOS). A normal level is roughly 1–3.5 ng/ml. A reduced level is 0.5–1 ng/ml, where reserve is below average and the protocol may need adapting. Below 0.5 ng/ml is low, with a significantly reduced reserve and an anticipated limited response to stimulation.
Crucially: 'normal' for AMH is heavily age-dependent. A level of 1 ng/ml at 42 is a very different situation from the same result at 30. Any result should be interpreted with a doctor, in the context of age and other findings.
This is the point most often missed. AMH is a marker of quantity, not quality. It tells you how many follicles are potentially available to respond to stimulation — but nothing about how good the eggs inside them will be.
Egg quality depends primarily on age. Age — not AMH — is the main predictor of success in fertility treatment. A woman with low AMH at 32 has considerably better chances than a woman with normal AMH at 42. AMH matters, but it doesn't replace or outweigh age.
AMH also doesn't predict the ability to conceive naturally. Studies show that women with reduced AMH and regular cycles have roughly the same likelihood of conceiving within a year as women with normal AMH of the same age. Low AMH signals less time in reserve, not the impossibility of pregnancy.
And AMH is not a diagnosis. It's one of several markers a doctor considers together: alongside the antral follicle count on ultrasound, FSH level, age and clinical history.
Declining AMH with age is physiologically normal. It's an inevitable process that begins with puberty and accelerates after 35 to 38. This is why fertility specialists emphasise that time matters — it's not alarmism, it's physiology.
Beyond age, AMH can decline for other reasons. Ovarian surgery — particularly the removal of cysts (endometriomas) — can significantly reduce reserve. This is why decisions about surgery for endometriosis always require weighing the risks to fertility. Chemotherapy and radiotherapy are toxic to follicles and can irreversibly deplete the reserve — hence the importance of egg cryopreservation before treatment.
Smoking reduces AMH — the mechanism isn't fully established, but the association is consistent. This is one of the few causes of AMH decline that can be addressed. Autoimmune conditions and genetic factors can also affect the rate of decline. In some cases the cause of an early drop remains unknown.
First and most important: don't panic. A single test result is not a diagnosis and not a verdict. The next step is meeting with a fertility specialist who will assess the full picture: AMH, antral follicle count, age, history, and the path to pregnancy you're considering.
If you're planning a pregnancy, don't delay. That doesn't mean making decisions in a panic. It means that if children are in your plans, information about a reduced reserve should factor into your thinking about timing.
With a low AMH, IVF remains a real option, though the protocol will be tailored. The doctor will choose a more aggressive stimulation protocol or, conversely, a milder one — depending on the individual response. With very low reserve, fewer eggs may be retrieved per cycle, sometimes requiring several cycles to accumulate enough embryos.
Natural conception with reduced AMH is possible — particularly when cycles are regular and ovulation is occurring. But the window for trying is shorter than with a normal reserve, and delaying attempts isn't advised.
Donor eggs are an option worth discussing if the remaining reserve is too low for successful IVF. This isn't a failure or a last resort — it's a medical tool that makes it possible to carry and deliver a child genetically related to a partner when one's own eggs aren't producing results.
This is a frequent question — and an honest answer is nuanced. Ovarian reserve declines irreversibly with age. No proven method exists to restore or meaningfully raise AMH in healthy women.
That said, some research is exploring potential influences. DHEA and CoQ10 are two supplements some clinics prescribe for reduced reserve. Evidence on them is mixed: some small studies show a modest positive effect on egg quality (not on AMH itself), others find no difference. The evidence base isn't yet strong enough for clear recommendations.
Stopping smoking, normalising weight and reducing chronic stress won't directly raise AMH, but they create better conditions for ovarian function and egg quality. These aren't alternatives to medical treatment, but a sensible backdrop to it.
A practical note: if you're retesting AMH to track change, make sure you use the same laboratory and the same assay method. Different methods produce different numerical values, and an apparent 'rise' may simply be a difference between labs.
If your AMH is declining but you're not yet ready for pregnancy, egg cryopreservation deserves a serious conversation. The earlier the freeze, the better the quality of the material preserved. A falling reserve makes waiting costly — quite literally.
On the other hand, with very low AMH, freezing may yield few eggs per cycle, reducing its effectiveness. Whether cryopreservation is worthwhile in a given situation is a conversation with a fertility specialist who can assess your likely response to stimulation.
AMH is a useful marker, not an oracle. It speaks to the quantity of reserve — not to egg quality, not to the likelihood of natural conception, and not to the overall prognosis in treatment.
Low AMH means: there is less time than one might wish, and any plan should take that into account. It does not mean: pregnancy is impossible, IVF won't help, or donor eggs are the only next step.
The right response to a low AMH result is informed action, not panic — a conversation with a specialist, a full assessment, an honest discussion of options, and timely decision-making.
AMH (Anti-Müllerian Hormone) — a protein produced by cells of small ovarian follicles. Blood levels reflect ovarian reserve. Not cycle-day dependent.
Antral follicles — small follicles visible on transvaginal ultrasound at the start of the cycle (2–10 mm in diameter). Their count is the second key marker of ovarian reserve alongside AMH.
CoQ10 (Coenzyme Q10) — an antioxidant involved in cellular energy metabolism. Some research explores its effect on egg quality with reduced reserve. Evidence remains limited.
DHEA (Dehydroepiandrosterone) — a hormonal precursor prescribed by some clinics for reduced ovarian reserve. Research findings are mixed.
Endometrioma — a cystic lesion in the ovary filled with old blood ('chocolate cyst'). Surgical removal carries a risk of reducing ovarian reserve.
FSH (Follicle-Stimulating Hormone) — a pituitary hormone driving follicle development. An elevated level on days 2–5 of the cycle also indicates reduced ovarian reserve, often alongside low AMH.
Ovarian reserve — the remaining supply of eggs in the ovaries. Declines irreversibly with age. Assessed through AMH and antral follicle count.
PCOS (Polycystic Ovary Syndrome) — an endocrine condition characterised by an abnormally high number of antral follicles. Can produce elevated AMH values.
Stimulation protocol — the regimen of hormonal medications used to mature multiple follicles before egg retrieval in IVF. Adapted individually when reserve is reduced.
Open Glossary →Join thousands building families on their own terms.
Browse Profiles